More than 400 cases of a new Omicron sub-variant have been identified in England.
The UK Health Security Agency (UKHSA) has described Omicron BA.2 as a “variant under investigation” and revealed that, so far, 426 infections have been confirmed in England.
Early analysis suggests it may spread faster than its parent, although scientists are not yet certain of this, hence it not being designated a “variant of concern” at this stage.
UKHSA said further analysis will be carried out into BA.2 to determine its characteristics and better understand how it could shape Britain’s experience of the pandemic in the weeks to come.
Dr Meera Chand, incident director at the UKHSA, said it is not yet clear if the sub-variant causes more severe disease, adding that it is natural for viruses to mutate.
“It’s to be expected that we will continue to see new variants emerge,” she said. “Our continued genomic surveillance allows us to detect them and assess whether they are significant.”
“So far, there is insufficient evidence to determine whether BA.2 causes more severe illness than Omicron BA.1, but data is limited and UKHSA continues to investigate.”
The areas with the most confirmed cases are London, with 146, and the southeast, with 97. The earliest confirmed case of the sub-variant dates back to 6 December 2021.
It is also not clear where precisely the sub-variant first emerged but the new strain has already been reported in 40 countries, including Denmark, India, Sweden and Singapore, according to the UKHSA.
In Denmark, BA.2 has risen rapidly. It accounted for 20 per cent of all Covid-19 cases in the final week of 2021, increasing to 45 per cent in the second week of 2022.
Initial analysis made by Denmark’s Statens Serum Institut (SSI) showed no difference in hospitalisations between Omicron BA.2 and the original Omicron strain, BA.1.
SSI researcher Anders Fomsgaard said he did not yet have a good explanation for BA.2’s rapid growth but said he was puzzled rather than worried.
“It may be that it is more resistant to the immunity in the population, which allows it to infect more. We do not know yet,” he told local media.
He added there was a possibility people infected with BA.1 might not be immune from catching BA.2 soon after.
“It is a possibility,” he said. “In that case, we must be prepared for it. And then, in fact, we might see two peaks of this epidemic.”
The UKHSA said of the strain in a statement: “As is routine for any new variants under investigation, UKHSA is carrying out laboratory and epidemiological investigations to better understand the characteristics of this variant.
“We will continue to monitor this situation closely and recommend appropriate public health measures if needed. More detail will be available in UKHSA’s regular variant technical briefings.”
